. 1957 Apr 6;31(14):329-35.

Tuberculosis as a possible aetiological factor in mental disorder, and the place of isoniazid in treatment; with five illustrative case reports

J J DU PLESSIS. S Afr Med J. 1957.

. 1957 Apr 6;31(14):329-35.

No abstract available

Similar articles

Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis.
Weiner M, Benator D, Burman W, Peloquin CA, Khan A, Vernon A, Jones B, Silva-Trigo C, Zhao Z, Hodge T; Tuberculosis Trials Consortium. Weiner M, et al. Clin Infect Dis. 2005 May 15;40(10):1481-91. doi: 10.1086/429321. Epub 2005 Apr 14. Clin Infect Dis. 2005. PMID: 15844071 Clinical Trial.
Lack of toxicity from concomitant directly observed disulfiram and isoniazid-containing therapy for active tuberculosis.
Burman WJ, Terra M, Breese P, Cohn D, Reves R. Burman WJ, et al. Int J Tuberc Lung Dis. 2002 Sep;6(9):839-42. Int J Tuberc Lung Dis. 2002. PMID: 12234141
[Which treatment for primary tuberculosis?].
Gallet S, Bellon G. Gallet S, et al. Pediatrie. 1989;44(9):699-704. Pediatrie. 1989. PMID: 2695890 Review. French.
Successful treatment with infliximab despite positive tuberculosis ELISpot results in a patient with pityriasis rubra pilaris taking prophylactic isoniazid.
Zirbs M, Kigitsidou E, Seifert F, Ring J, Brockow K. Zirbs M, et al. Clin Exp Dermatol. 2011 Oct;36(7):808-9. doi: 10.1111/j.1365-2230.2011.04074.x. Epub 2011 Apr 20. Clin Exp Dermatol. 2011. PMID: 21507042 No abstract available.
Tuberculosis chemoprophylaxis.
Salpeter S. Salpeter S. West J Med. 1992 Oct;157(4):421-4. West J Med. 1992. PMID: 1462535 Free PMC article. Review.